Hotchkis & Wiley Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
214,150
+77,350
+57% +$3.98M 0.03% 281
2026
Q1
$8.11M Buy
+136,800
New +$8.88M 0.03% 293
2022
Q4
Sell
-178,230
Closed -$8.88M 533
2022
Q3
$8.88M Buy
178,230
+90,830
+104% +$5.03M 0.04% 146
2022
Q2
$5.14M Buy
87,400
+1,700
+2% +$93.7K 0.02% 315
2022
Q1
$4.54M Buy
85,700
+10,550
+14% +$609K 0.01% 383
2021
Q4
$4.56M Buy
+75,150
New +$4.46M 0.01% 364

Other funds holding PBH

Hotchkis & Wiley Capital Management's PBH Position: Q2 2026 in Review

Hotchkis & Wiley Capital Management increased its Prestige Consumer Healthcare (PBH) stake by 57% in Q2 2026, buying an estimated $3.98M and bringing the position to 214,150 shares worth $10.1M. The position accounts for 0.03% of the portfolio, ranked #281.

Hotchkis & Wiley Capital Management first reported a position in PBH in Q4 2021 and has held it in 6 quarters since. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Hotchkis & Wiley Capital Management held 214,150 shares of Prestige Consumer Healthcare worth $10.1M as of Q2 2026.
  • Hotchkis & Wiley Capital Management bought 77,350 Prestige Consumer Healthcare shares in Q2 2026, an estimated $3.98M.
  • Prestige Consumer Healthcare made up 0.03% of Hotchkis & Wiley Capital Management's portfolio in Q2 2026, its #281 holding.
  • Hotchkis & Wiley Capital Management first reported a position in Prestige Consumer Healthcare in Q4 2021 and has held it in 6 quarters since.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.